ZOGA

This brand name is authorized in Nigeria.

Active ingredients

The drug ZOGA contains one active pharmaceutical ingredient (API):

1	Sildenafil UNII BW9B0ZE037 - SILDENAFIL CITRATE
	Sildenafil is a potent and selective inhibitor of cyclic guanosine monophosphate (cGMP) specific phosphodiesterase type 5 (PDE5), the enzyme that is responsible for degradation of cGMP. Apart from the presence of this enzyme in the corpus cavernosum of the penis, PDE5 is also present in the pulmonary vasculature. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation.
	Read more about Sildenafil

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-0222	Tablet	ZOGA 100 SILDENAFIL CITRATE TABLETS TAB 100 mg 1 X 4	6 CMS-PP-272125 ZOGA 100 SILDENAFIL CITRATE TABLETS 100MG Sildenafil citrate 100mg, Magnesium stearate, Talc powder, Corn starch, Methy paraben B4-0222 Drugs VARIOUS Nigerian Products 1x4 POM 1 6/27/2022 KCH CONSUMER HEALTHCARE LIMITED, 2B, KWAME NKRUMAH LANE, CROWN ESTATE LEKKI EPE EXPRESSWAY AJAH LEKKI LAGOS 8032317925 Kchconsumer@gmail.com KCH Consumer Healthcare Ltd., Plot 1-6 KCH Close, Off Atlantic Hall Expressway, Poka, Lekki Free Trade Zone, Epe, Lagos., Nigeria	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G04BE03	Sildenafil	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BE Drugs used in erectile dysfunction
Discover more medicines within G04BE03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-0222